Good write up. A few comments:
-
Currently, KNRH does not host the largest Uganda's largest tertiary infectious diseases unit; Mulago National Referral does. You can be more specific by stating that during that time (2017-2022) KNRH hosted the countries largest tertiary ID unit. During that period of time, MNRH was under renovation and closed.
-
Uganda's clinicians experienced in HIV and CM management are known and these are not mentioned as either your co-authors or in the acknowledgments. It is uncertain whether indeed they reviewed your data abstraction tool.
-
KNRH is a clinical trial site for patients diagnosed with HIV and CM with a robust team of clinicians offering a highly specialised treatment to study participants diagnosed with HIV associated CM. As a result, the hospital rarely suffers from drug stock outs, diagnostic challenges or disease/treatment management challenges. Compared to what you would find if this study is carried another hospital in say rurral Uganda, It is unlikely that your findings represent real world setting.
-
Between 2017 and 2022, there were about 3 clinical trials that were carried out at KNRH with each trial investigating a different antifungal agent/treatment regimen. Your findings would be more accurate if they are stratified as per patient arm. Alternatively you can list as a limitation to your observations. Also, can you look at mortality by different years, as the treatment regimens kept on changing, mortality changed as well. You may want to consider those who received standard of care and exclude those who received experimental treatment.
-
It appears your cut off for long hospital stay is more than 7 days. Clarify this in your methods. I suggest you consider moving it to more than 14 days because as part standard procedure, the participants were kept in hospital deliberately for a minimum of 14 days except in scenarios were they asked to be discharged before the end of the second week. As you may recall between 2017 and 2022 Uganda was using IV deoxycholate for induction phase treatment of CM which was administered for 2 weeks.
-
Finally, there is a specific group of individuals who invested both resources and time to collect this data. The least you can do is mention them in the acknowledgements.